Phase I Trial of Intratumoral Administration of Vesicula

Project: Research project

Description

Phase I Trial of Intratumoral Administration of Vesicular Stomatitis Virus Genetically Engineered to Express NIS and human interferon beta (VSV-IFN-NIS), in Patients with Refractory Solid Tumors, VYRVSV2-101
StatusActive
Effective start/end date1/1/171/1/20

Funding

  • VYRIAD

Fingerprint

Vesicular Stomatitis
Interferon-beta
Viruses
Neoplasms